• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    144.37 Up 3.84(2.73%) May 3, 4:00PM EDT
    Prev Close:140.53
    Open:141.71
    Bid:141.58 x 100
    Ask:147.36 x 100
    1y Target Est:195.74
    Beta:1.42705
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:141.00 - 147.79
    52wk Range:124.16 - 208.88
    Volume:2,259,306
    Avg Vol (3m):1,699,180
    Market Cap:32.44B
    P/E (ttm):215.48
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 2.73%32.44B
    AMGNDown 1.66%117.42B
    BAXDown 0.72%24.42B

    Key Statistics

    Forward P/E (1 yr):21.94
    P/S (ttm):12.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.05
    Quarterly EPS Est (Jun-16) :1.18
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback